Alpa Laboratories Past Earnings Performance
Past criteria checks 2/6
Alpa Laboratories has been growing earnings at an average annual rate of 32.4%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 4.5% per year. Alpa Laboratories's return on equity is 12.6%, and it has net margins of 21.4%.
Key information
32.4%
Earnings growth rate
32.4%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 4.5% |
| Return on equity | 12.6% |
| Net Margin | 21.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now
Sep 22
Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market
Sep 06We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings
Jun 08Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely
Jun 03Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today
Dec 14Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why
Sep 23Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors
Aug 26Is Alpa Laboratories (NSE:ALPA) A Risky Investment?
Jan 19Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?
Jun 17If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late
Feb 23Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear
Nov 24Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today
Oct 05Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?
May 31With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting
Jan 28Revenue & Expenses Breakdown
How Alpa Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 973 | 208 | 161 | 0 |
| 30 Jun 24 | 1,087 | 162 | 133 | 0 |
| 31 Mar 24 | 1,087 | 168 | 156 | 0 |
| 31 Dec 23 | 1,148 | 178 | 135 | 0 |
| 30 Sep 23 | 1,148 | 185 | 132 | 0 |
| 30 Jun 23 | 1,054 | 130 | 124 | 0 |
| 31 Mar 23 | 930 | 126 | 125 | 0 |
| 31 Dec 22 | 1,007 | 45 | 121 | 0 |
| 30 Sep 22 | 1,012 | 48 | 121 | 0 |
| 30 Jun 22 | 1,139 | 103 | 118 | 0 |
| 31 Mar 22 | 1,123 | 141 | 123 | 0 |
| 31 Dec 21 | 1,121 | 156 | 116 | 0 |
| 30 Sep 21 | 1,159 | 139 | 125 | 0 |
| 30 Jun 21 | 1,128 | 105 | 121 | 0 |
| 31 Mar 21 | 976 | 72 | 120 | 0 |
| 31 Dec 20 | 907 | 69 | 126 | 0 |
| 30 Sep 20 | 817 | 58 | 118 | 0 |
| 30 Jun 20 | 821 | 39 | 115 | 0 |
| 31 Mar 20 | 860 | 19 | 122 | 0 |
| 31 Dec 19 | 869 | 9 | 129 | 0 |
| 30 Sep 19 | 888 | 6 | 128 | 0 |
| 30 Jun 19 | 817 | 11 | 127 | 0 |
| 31 Mar 19 | 780 | 10 | 126 | 0 |
| 31 Mar 18 | 628 | 28 | 106 | 0 |
| 31 Mar 17 | 635 | 25 | 89 | 0 |
| 31 Mar 16 | 536 | 68 | 99 | 0 |
| 31 Mar 15 | 574 | -14 | 88 | 0 |
| 31 Dec 14 | 618 | -19 | 136 | 0 |
| 30 Sep 14 | 627 | -46 | 138 | 0 |
| 30 Jun 14 | 573 | -60 | 138 | 0 |
| 31 Mar 14 | 567 | -52 | 135 | 0 |
| 31 Dec 13 | 566 | -66 | 119 | 0 |
Quality Earnings: ALPA has a high level of non-cash earnings.
Growing Profit Margin: ALPA's current net profit margins (21.4%) are higher than last year (16.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ALPA's earnings have grown significantly by 32.4% per year over the past 5 years.
Accelerating Growth: ALPA's earnings growth over the past year (12.6%) is below its 5-year average (32.4% per year).
Earnings vs Industry: ALPA earnings growth over the past year (12.6%) did not outperform the Pharmaceuticals industry 20.4%.
Return on Equity
High ROE: ALPA's Return on Equity (12.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 10:47 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alpa Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anil Burra | FirstCall Research |